The article highlights how Takeda, the main manufacturer of ADHD medications, is grappling with ongoing supply issues, which are expected to persist until April 2024.
You can read the full article here: https://www.chemistanddruggist.co.uk/CD137786/Pharmacies-field-calls-from-anxious-patients-as-ADHD-med-shortages-persist
